Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Derwent London Picks Former JP Morgan London Executive For Chair

Tue, 26th Jan 2021 10:21

(Alliance News) - Derwent London PLC on Tuesday said it has appointed the former vice chair of Global M&A at JPMorgan in London to its board, with the intention of making him company chair.

The property investment and development business, primarily operating in London, has appointed Mark Breuer to its board as an independent non-executive director, effective February 1.

Breuer retired in 2017 from a 20-year career at JPMorgan in London, where he has been vice chair of Global M&A and a member of the Global Strategic Advisory Council.

Provided share approval is granted, Breuer will be made non-executive chair of Derwent following the conclusion of the company's 2021 annual general meeting, where current chair John Burns will retire.

At present, Breuer serves on the board of Irish support services firm DCC PLC as senior independent director and is a non-executive director at biotech sector-focused investor Arix Bioscience PLC.

Shares in Derwent were up 0.3% at 3,116.00 pence in London on Tuesday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
12 Feb 2024 12:53

IN BRIEF: Arix Bioscience shares suspended ahead of RTW takeover

Arix Bioscience PLC - London-based venture capital firm focused on biotechnology companies - Shares suspended from the London Stock Exchange amid the ...

5 Feb 2024 16:05

UK shareholder meetings calendar - next 7 days

22 Jan 2024 16:22

IN BRIEF: RTW Biotech completes Arix investment in takeover run-up

RTW Biotech Opportunities Ltd - New York-based investment firm focused on the life sciences sector - Says it completed on Friday its previously announ...

19 Jan 2024 11:29

IN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon sale

Arix Bioscience PLC - London-based venture capital firm investing in "breakthrough" biotechnology companies - Expects USD18.6 million net proceeds fro...

1 Nov 2023 12:19

RTW Biotech agrees "immediately accretive" Arix Bioscience takeover

(Alliance News) - RTW Biotech Opportunities Ltd on Wednesday said it has agreed to acquire all the assets of fellow London listing Arix Bioscience PLC...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.